AQ-13
- Generic Name
- AQ-13
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H24Cl3N3
- CAS Number
- 169815-40-1
- Unique Ingredient Identifier
- PKT9732S5K
- Background
AQ-13 is an 4-aminoquinoline analog being investigated for the treatment of malaria.
- Associated Conditions
- -
- Associated Therapies
- -
Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Tulane University Health Sciences Center
- Target Recruit Count
- 14
- Registration Number
- NCT00455494
- Locations
- 🇺🇸
Tulane-LSU General Clinical Research Center, New Orleans, Louisiana, United States
Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Tulane University Health Sciences Center
- Target Recruit Count
- 122
- Registration Number
- NCT00323375
- Locations
- 🇺🇸
Tulane-LSU-Charity Hospital General Clinical Research Center, New Orleans, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath